MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-KR-03-0027838
Kasturba Pharmaceuticals Private Limited
Kasturba Pharmaceuticals Private Limited - chemicals in Bangalore, Karnataka, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹1 Lakh
Latest filing
Net loss · FY 2024
₹3.56 Lakh
Net margin -355.8%
EBITDA · FY 2024
-₹2.99 Lakh
EBITDA margin -298.6%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
11 yrs
Est. 2015
Directors on board
3
As per MCA filings
Active GSTINs
1
GST registered
About Kasturba Pharmaceuticals Private Limited
Data last updated:
Kasturba Pharmaceuticals Private Limited is a private limited company based in Bangalore, Karnataka, India. It operates in the chemical products segment of the chemicals sector. It was incorporated on 10 September 2015 and has been in existence for over 11 years.
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U24230KA2015PTC082784. Its GSTIN is 29AAFCK9906K1ZX (Karnataka).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Hasina Ahmed and Abdul Khader.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at #19 9th Cross 9th Main Behind Vet College Jp Nagar 2nd Phase Bangalore, Karnataka, India – 560078.
As per the financials filed for FY 2024, the company reported a revenue of ₹1 Lakh. For the same year it recorded a net loss of ₹3.56 Lakh (net margin -355.8%) and EBITDA of -₹2.99 Lakh (EBITDA margin -298.6%). Revenue has declined at a compounded annual rate (CAGR) of 41% over three years.
Kasturba Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-KR-03-0027838). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U24230KA2015PTC082784
Registration Number 082784
Incorporation Date 10 September 2015
ROC Bangalore
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-KR-03-0027838
Recognitions & Rankings of Kasturba Pharmaceuticals
Contact details
Kasturba Pharmaceuticals Private Limited's registered office is in Bangalore, Karnataka. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address#19 9th Cross 9th Main Behind Vet College Jp Nagar 2nd Phase Bangalore, Karnataka, India – 560078
- IndustryChemicals, Chemical Products, Medicinal Chemical & Botanical Products, Pharmaceuticals
To see the full contact details of Kasturba Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Kasturba Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Kasturba Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Kasturba Pharmaceuticals Private Limited, buy the company report.
Financials of Kasturba Pharmaceuticals Private Limited
FY 2025 filings availableKasturba Pharmaceuticals Private Limited reported revenue of ₹1 Lakh for FY 2024.
Revenue · FY 2024
₹1 Lakh
Net loss · FY 2024
₹3.56 Lakh margin -355.8%
EBITDA · FY 2024
-₹2.99 Lakh margin -298.6%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
3 years · compounded
▼ 41%
EBITDA CAGR growth
1 year
▲ 46%
3 years · compounded
▼ 110%
5 years · compounded
▼ 65%
Revenue has declined at a compounded annual rate (CAGR) of 41% over three years. EBITDA rose 46% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹2.99 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹3.56 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -298.6% | ||||
| Net Profit Margin | -355.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Kasturba Pharmaceuticals Private Limited, buy the company report.
Board of directors of Kasturba Pharmaceuticals Private Limited
Kasturba Pharmaceuticals has 3 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Hasina Ahmed | Director | 08 Mar 2024 | 2 Years 7 Months | Current |
| Abdul Khader | Director | 10 Sep 2015 | 11 Years 1 Months | Current |
| Ershad Shafi Ahmed | Director | 10 Sep 2015 | 11 Years 1 Months | Current |
Peer comparison
Kasturba Pharmaceuticals Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Medinode Pharmaceuticals Private Limited | ₹1.04 Lakh (FY 2025) | -55.0% | Aligarh, Uttar Pradesh, India | |||
| Nazwin Pharmaceuticals Private Limited | ₹1 Lakh (FY 2019) | Nagpur, Maharashtra, India | ||||
| Kasturba Pharmaceuticals Private Limitedthis company | ₹1 Lakh (FY 2024) | -₹3.56 Lakh | -355.8% | Bangalore, Karnataka, India | ||
| Colikine Pharmaceuticals Private Limited | ₹1 Lakh (FY 2018) | -61.0% | Ghazipur, Uttar Pradesh, India | |||
| Nishchay Pharmaceuticals Private Limited | ₹99,532 (FY 2015) | Panchkula, Haryana, India |
To see the full peer comparison of Kasturba Pharmaceuticals Private Limited, buy the company report.
Auditor
Kasturba Pharmaceuticals Private Limited is audited by USHASHANMUGAM CHANDRAN for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| USHASHANMUGAM CHANDRAN | FY 2017 | 224749 |
Shareholding
The shareholding of Kasturba Pharmaceuticals Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Kasturba Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Kasturba Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Kasturba Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Kasturba Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 29AAFCK9906K1ZX | Karnataka | Active | 09 Dec 2017 |
To see the full GST registrations and return filing status of Kasturba Pharmaceuticals Private Limited, buy the company report.
Recent activity
Kasturba Pharmaceuticals Private Limited has 3 board changes on record since 2015: 3 appointments. The latest: Hasina Ahmed was appointed as Director on 08 Mar 2024.
AGM
Kasturba Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Kasturba Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Bangalore.
Appointed
Hasina Ahmed was appointed as Director.
Appointed
Abdul Khader was appointed as Director.
Appointed
Ershad Shafi Ahmed was appointed as Director.
Incorporation
10 Sep 2015
Kasturba Pharmaceuticals Private Limited was registered on 10 Sep 2015 with Roc Bangalore & aged 11 years 1 month as per MCA records.
Frequently asked questions
Kasturba Pharmaceuticals is an active private limited company based in Bangalore, Karnataka, India. The company works in chemical products, within the chemicals industry. It was incorporated on 10 September 2015 (11+ years old) and is registered under CIN U24230KA2015PTC082784.
Kasturba Pharmaceuticals has 3 current directors:
- Hasina Ahmed - Director
- Abdul Khader - Director
- Ershad Shafi Ahmed - Director
The latest financial statements of Kasturba Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2016 are in the company report.
The GSTIN of Kasturba Pharmaceuticals is 29AAFCK9906K1ZX, registered in Karnataka.
The CIN (Corporate Identification Number) of Kasturba Pharmaceuticals is U24230KA2015PTC082784. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Kasturba Pharmaceuticals was incorporated on 10 September 2015, making it 11+ years old. It is registered with the Registrar of Companies, Bangalore.
The peers of Kasturba Pharmaceuticals by revenue are Medinode Pharmaceuticals Private Limited, Nazwin Pharmaceuticals Private Limited, Colikine Pharmaceuticals Private Limited, Nishchay Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Hasina Ahmed was appointed as Director on 08 Mar 2024. Abdul Khader was appointed as Director on 10 Sep 2015. Ershad Shafi Ahmed was appointed as Director on 10 Sep 2015.
Yes, Kasturba Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-KR-03-0027838).
The registered office of Kasturba Pharmaceuticals is at #19 9th Cross 9th Main Behind Vet College Jp Nagar 2nd Phase Bangalore, Karnataka, India – 560078.
Kasturba Pharmaceuticals operates in the chemicals industry, in the chemical products segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages